Airmid Incorporated, Redwood City, California, USA.
Pain Pract. 2013 Feb;13(2):114-30. doi: 10.1111/j.1533-2500.2012.00564.x. Epub 2012 May 28.
Chronic pain--especially that which is refractory to conventional treatment--presents particular challenges to physicians and patients. Examination of the molecular and cellular mechanisms involved in this pathophysiology suggests that spinal instillation of therapeutic agents may offer an effective treatment option through the modification of the processing and sensation of chronic pain. Intrathecal therapy, used alone or in combination with other analgesic agents, may reduce chronic pain by attenuating both pre- and postsynaptic activities. This article reviews chronic pain pathophysiology and the mechanisms whereby spinally administered analgesics may modify chronic pain. Available treatment options are also considered, including recommendations from the 2007 Polyanalgesic Consensus Conference (PACC) guidelines on the use of intrathecal agents for nociceptive, neuropathic, and mixed pain.
慢性疼痛——尤其是对常规治疗有抗性的疼痛——给医生和患者带来了特殊的挑战。对涉及这种病理生理学的分子和细胞机制的研究表明,通过改变慢性疼痛的处理和感知,向脊髓内注入治疗药物可能提供一种有效的治疗选择。鞘内治疗单独使用或与其他镇痛药物联合使用,通过减轻突触前和突触后的活动,可能减轻慢性疼痛。本文综述了慢性疼痛的病理生理学以及鞘内给予的镇痛药可能改变慢性疼痛的机制。还考虑了可用的治疗选择,包括 2007 年多模式镇痛共识会议(PACC)关于鞘内药物用于伤害感受性、神经性和混合性疼痛的使用指南中的建议。